Related Experiment Video
Updated: Feb 3, 2026

Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass
Published on: July 14, 2023
Minimal Clinically Important Improvement of Routine Assessment of Patient Index Data 3 in Rheumatoid Arthritis
Michael M Ward1,2, Isabel Castrejon3,4, Martin J Bergman3,4
1From the Intramural Research Program, US National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, Maryland; Division of Rheumatology, Rush University Medical Center, Chicago, Illinois; Rheumatology, Taylor Hospital, Ridley Park, Pennsylvania, USA. wardm1@mail.nih.gov.
Objective:
To estimate minimal clinically important improvement (MCII) of RAPID-3 (Routine Assessment of Patient Index Data 3) in rheumatoid arthritis (RA).
Methods:
RAPID-3 was computed before and after treatment escalation in a prospective study of adults with active RA. Patient judgment of improvement was used as the standard for a receiver-operating characteristic curve, from which MCII was estimated.
Results:
Mean RAPID-3 improved from 16.3 to 11.1 between visits. MCII was -3.8 based on simultaneously optimized sensitivity and specificity, -3.5 using the 0.80 specificity criterion, and -4.1 using the Youden index.
Conclusion:
RAPID-3 improvement of 3.8/30 units appears clinically meaningful.
Insights
A minimal clinically important improvement (MCII) for Routine Assessment of Patient Index Data 3 (RAPID-3) in rheumatoid arthritis (RA) was estimated. An improvement of 3.8/30 units on the RAPID-3 score indicates a meaningful change for RA patients.
Area of Science:
- Rheumatology
- Clinical Measurement
- Patient-Reported Outcomes
Background:
- Rheumatoid arthritis (RA) management relies on assessing treatment efficacy.
- Routine Assessment of Patient Index Data 3 (RAPID-3) is a composite index for monitoring RA.
- Establishing a minimal clinically important improvement (MCII) for RAPID-3 is crucial for clinical interpretation.
Purpose of the Study:
- To determine the MCII for the RAPID-3 score in adult patients with active rheumatoid arthritis.
- To provide a quantitative measure of clinically meaningful improvement in RA patients using RAPID-3.
Main Methods:
- A prospective study involving adults with active RA.
- RAPID-3 scores were collected before and after treatment escalation.
- Patient-reported improvement was used as the reference standard to derive MCII via receiver-operating characteristic (ROC) curve analysis.
Main Results:
- Mean RAPID-3 scores decreased from 16.3 to 11.1, indicating improvement.
- MCII estimates ranged from -3.5 to -4.1, with -3.8 derived from simultaneously optimized sensitivity and specificity.
- The calculated MCII suggests a meaningful change in RA disease activity.
Conclusions:
- An improvement of 3.8/30 units on the RAPID-3 score is considered clinically meaningful for RA patients.
- This finding aids clinicians in interpreting RAPID-3 changes and assessing treatment effectiveness.
- The study establishes a benchmark for clinically significant improvement in RA using a validated patient-reported outcome measure.
Related Concept Videos
Statistical Software for Data Analysis and Clinical Trials
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Data Reporting and Recording
Angina III: Clinical Manifestations and Assessment
Nursing Process for Patient and Caregiver Teaching I: Assessment and Diagnosis
It is critical to determine the patient's learning needs during the assessment. Determination of learning needs compounds data...

